Skip to content
aiqbenchAI & Quantum Intelligence
NewsInsightsBenchmarksSkillsAsk AILearnAbout
...Loading your session
NewsInsightsBenchmarksSkillsAsk AILearnAbout
Back to list
aiqbench takeMachine Learning

aiqbench analysis

This research applies offline reinforcement learning to optimize sequential chemotherapy regimens using real-world colon cancer clinical data. By implementing a model-based architecture with conservative Q-learning, the study aims to assist oncologists in scheduling personalized treatment protocols.
1
Source coveringarXiv

Reinforcement Learning based control of Cancer Chemotherapy treatments

arXiv·November 11, 2026·3 min read

From arXiv

Full text

arXiv:2611.12940v1 Announce Type: cross Abstract: Reinforcement Learning has achieved tremendous success in recent years. Extending its scope from the traditional complex games such as Atari, Go, Pokeman, and Chess, reinforcement learning has caught researchers' attention on modelling real-life scenarios. Personalized medicine and the dynamic treatment regimen are two such preliminary research fields; researchers are focusing their mindsets currently. Estimating the optimal dynamic treatment regimens from the observational real clinical data is being popularized among the researchers, widening its scope towards more advanced versions of reinforcement learning algorithms.

This research is about a research study that focused on reinforcement learning techniques that have been approached in the context of cancer chemotherapy treatments. Primarily this thesis addresses the result of the study by means of the state-of-the-art on reinforcement learning techniques used in generating the optimal policy for sequential treatments, including the existing online reinforcement learning approaches. Thereby a simulation for cancer chemotherapy via traditional Q-learning would be presented.

Secondly, the study will extend towards using offline reinforcement learning in the optimal policy generation. Thus, the proposed solution follows a data-driven approach, which works on the real human colon cancer clinical data. The novelty of the proposed solution resides in the implementation of an offline reinforcement learning approach by means of a model-based architecture using the conservative Q-learning and the model-based offline policy optimization algorithm. As per the experimental results and the evaluations, it was revealed that the proposed Chemo RL model caters well the problem of cancer chemotherapy treatment scheduling and serves as a supportive model for the junior oncologists in deciding their treatment decisions.

Abstract:Reinforcement Learning has achieved tremendous success in recent years. Extending its scope from the traditional complex games such as Atari, Go, Pokeman, and Chess, reinforcement learning has caught researchers' attention on modelling real-life scenarios. Personalized medicine and the dynamic treatment regimen are two such preliminary research fields; researchers are focusing their mindsets currently. Estimating the optimal dynamic treatment regimens from the observational real clinical data is being popularized among the researchers, widening its scope towards more advanced versions of reinforcement learning algorithms.

This research is about a research study that focused on reinforcement learning techniques that have been approached in the context of cancer chemotherapy treatments. Primarily this thesis addresses the result of the study by means of the state-of-the-art on reinforcement learning techniques used in generating the optimal policy for sequential treatments, including the existing online reinforcement learning approaches. Thereby a simulation for cancer chemotherapy via traditional Q-learning would be presented.

Secondly, the study will extend towards using offline reinforcement learning in the optimal policy generation. Thus, the proposed solution follows a data-driven approach, which works on the real human colon cancer clinical data. The novelty of the proposed solution resides in the implementation of an offline reinforcement learning approach by means of a model-based architecture using the conservative Q-learning and the model-based offline policy optimization algorithm. As per the experimental results and the evaluations, it was revealed that the proposed Chemo RL model caters well the problem of cancer chemotherapy treatment scheduling and serves as a supportive model for the junior oncologists in deciding their treatment decisions.

Masters thesis at the National Taipei University. Received the IEEE Taipei Section, Best Masters thesis award in 2021

Artificial Intelligence (cs.AI); Machine Learning (cs.LG)

arXiv:2611.12940 [cs.AI]

(or arXiv:2611.12940v1 [cs.AI] for this version)

https://doi.org/10.48550/arXiv.2611.12940 Focus to learn more arXiv-issued DOI via DataCite

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.

Full text under the publisher's open licence · 372 words

Read at arXiv ↗Ask about this article

Related coverage

AI & Society

Adaptive Chemotherapy Control under Tumor Heterogeneity via Reinforcement Learning

arXiv · Sep 14, 2026

Machine Learning

AI isn’t close to curing cancer. This startup says it knows what it will take.

TechCrunch · Aug 19, 2026

Article info

Source

arXiv

Published

November 11, 2026

Read time

3 min

Category

Machine Learning
aiqbench
AI & Quantum Intelligence© aiqbench. All rights reserved.

Feeds:RSS·JSON Feed

LanguageEnglish·Românăbeta
NewsAI & TechQuantumInsights
ExploreBenchmarksLearn
CompanyAboutTrustLegal noticeTerms of ServicePrivacy PolicyCopyright noticesData erasureReport content

The aiqbench take, the insights, the daily digest and Ask answers are written by AI models from the sources shown, without editorial review before publication. They may contain errors — check the source. How the model is used →

  • News
  • Insights
  • Ask AI
  • Benchmarks
  • Account